In a nutshell The main objective of this trial is to determine the effectiveness and durability of a combined group of drugs (exenatide [Byetta], pioglitazone [Actos] and metformin [Glucophage]) compared to standard treatment in type 2 diabetes. The main outcome to be measured will be the change in HbA1c (average blood glucose over 3 months). The...
Read MoreDiabetes-related condition(s)-None Posts on Medivizor
Setting Personalized Blood Sugar Targets in Type 2 Diabetes
This article aimed to provide guidelines for setting personalized blood sugar level targets. The main conclusion was that these targets should be flexible and adapted to patients characteristics. Type 2 diabetes usually requires tight blood sugar control in order to prevent and minimize complications. If control is not achieved through lifestyle...
Read MoreStem Cell applications for the treatment of type 1 diabetes
In a nutshell The present study reviewed the current medical literature for new data on immunological applications involving stem cells for the treatment of type 1 diabetes mellitus (T1DM). Some background T1DM is an autoimmune disease caused by a destruction of the insulin-producing cells (IPC) in the pancreas. This means that the immune system,...
Read MoreThe impact of three educational strategies on poorly controlled diabetes: An intervention trial
In a nutshell The present study compared the effectiveness of 3 educational strategies aimed at helping patients with uncontrolled diabetes (type 1 and type 2) to achieve glycemic control (good control of blood sugar). All 3 strategies had beneficial effects on glycemic control. Most effective was an intervention based on behavioral group...
Read More
